NEW YORK and LONDON, September 19, 2017 – Akari Therapeutics (NASDAQ:AKTX), an emerging growth, clinical-stage biopharmaceutical company, is pleased to announce its Chief Executive Officer Dr. David Horn Solomon and Chief Operations Officer Clive Richardson will present at the Cantor Fitzgerald Global Healthcare Conference on Tuesday September 26, 2017 in New York City. The presentation is scheduled for 10:55am.
To access the live webcast of the presentation, visit the Investor Relations section of Akari Therapeutics at www.akaritx.com.
Akari is focused on the development and commercialization of treatments for a range of rare and orphan autoimmune and inflammatory diseases caused by the dysregulation of complement C5 and/or leukotriene B4 (LTB4).
Click here to view the full press release.
To watch the presentation in realtime on September 26 at 10:55am, click here.
